PROCTER & GAMBLE's PEPTO HEARTBURN CONTROL ENTERS TEST MARKETING
This article was originally published in The Tan Sheet
Executive Summary
PROCTER & GAMBLE's PEPTO HEARTBURN CONTROL ENTERS TEST MARKETING in Phoenix and Tucson, Ariz. the week of Nov. 7, the company announced. Pepto Heartburn Control, which does not include bismuth subsalicylate as an active ingredient, is the second "specialized" Pepto-brand product developed by P&G. Pepto Diarrhea Control, which contains loperamide, was launched at the end of 1992.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning